368 JOURNAL OF CHEMICAL RESEARCH 2012
Scheme 2 Proposed mechanism.
5,5-bis(4-Chlorophenyl)-3-{2-[(cyclohexylimino)methyl]-1,2-dihy-
droisoquinolin-1-yl}-2-thioxoimidazolidin-4-one (4b): White crystals;
m.p. (decomp.) 310–313 °C. yield (0.49 g, 86%). IR (KBr): 1704
(C=O), 1653 (C=S), 1560 (C=N) cm−1. 1H NMR (400 MHz,
DMSO-d6): δ = 0.93–1.14 (6 H, m, 3CH2), 1.26–1.39 (4 H, m, 2CH2),
2.74–2.81 (1 H, m, CH), 4.22 (1 H, s, CH), 6.11–7.89 (14 H, m, H-Ar,
N–CH=CH), 8.1 (1 H, s, CH), 9.6 (1 H, s, NH). 13C NMR (100 MHz,
DMSO-d6): δ = 28.9 (CH2), 29.8 (CH2), 30.2 (CH2), 30.7 (CH2), 31.0
(CH2), 65.3 (CH), 73.2 (C), 90.8 (N–CH–N), 114.5, 122.8, 123.3,
125.2, 126.0, 127.5, 128.7, 129.9, 130.2, 130.9, 138.3, 142.4 (C-Ar,
N–CH=CH), 172.3 (C=O), 181.4 (C=N), 182.3 (C=S). MS (EI), m/z
574 (M, 2%), 262 (3), 234 (7), 129 (2), 111 (16), 83 (10), 43 (100).
Anal.Calcd forC31H28Cl2N4OS (575.55): C, 64.69; H, 4.90; N, 9.73; S,
5.57%. Found: C, 64.59; H, 4.85; N, 9.65; S, 5.64%.
5,5-bis(4-Chlorophenyl)-2-thioxo-3-{2-[(2,4,4-trimethylpentan-2-
ylimino)methyl]-1,2-dihydroisoquinolin-1-yl}imidazolidin-4-one
(4e): White crystals; m.p. (decomp.) 236–240 °C. yield (0.51 g, 85%).
1
IR (KBr): 1710 (C=O), 1640 (C=S), 1553 (C=N) cm−1. H NMR
(400 MHz,DMSO-d6): δ = 1.03 (9 H,s, 3CH3), 1.31 (6 H, s, 2CH3),
1.64 (2 H, d, CH2), 4.18 (1 H, s, CH), 6.06–7.81 (14 H, m, H-Ar, N–
CH=CH), 8.18 (1 H, s, CH), 9.68 (1 H, s, NH). 13C NMR (100 MHz,
DMSO-d6): δ = 29.5 (C(CH3)2), 30.3 (C(CH3)2), 31.9 (C(CH3)3), 32.4
(CH2), 56.8 (C(CH3)3), 60.1 (C(CH3)2), 82.1 (C), 92.0 (N–CH–N),
112.7, 124.8, 126.1, 126.9, 127.2, 127.9, 128.8, 130.1, 131.8, 132.0,
135.9, 140.3 (C-Ar, N–CH=CH), 168.2 (C=O), 177.9 (C=N), 183.1
(C=S). Anal.Calcd for C33H34Cl2N4OS (605.62): C, 65.45; H, 5.66; N,
9.25; S, 5.29%. Found: C, 65.54; H, 5.70; N, 9.32; S, 5.22%.
5,5-Diphenyl-2-thioxo-3-{2-[(tosylmethylimino)methyl]-1,2-dihy-
droisoquinolin-1-yl}imidazolidin-4-one (4f): White crystals; m.p.
(decomp.) 284–287 °C. yield (0.56 g, 95%). IR (KBr): 1715 (C=O),
3-{2-[(Cyclohexylimino)methyl]-1,2-dihydroisoquinolin-1-yl}-2-
thioxo-5,5-di-p-tolylimidazolidin-4-one (4c): White crystals; m.p.
(decomp.) 232–236 °C. yield (0.43 g, 82%). IR (KBr): 1698 (C=O),
1
1652 (C=S), 1557 (C=N) cm−1. H NMR (400 MHz, DMSO-d6):
δ = 2.45 (3 H,s, CH3), 4.66–4.67 (2 H, d, CH2), 4.25 (1 H, s, CH),
6.08–7.69 (20 H, m, H-Ar, N–CH=CH), 8.04 (1 H, s, CH), 9.54 (1 H,
s, NH); 13C NMR (100 MHz, DMSO-d6): δ = 25.3 (CH3), 82.1 (C),
87.0 (CH2), 90.3 (N–CH–N), 115.8, 122.9, 124.4, 125.6, 126.2, 127.3,
127.4, 128.0, 128.1, 129.0, 129.4, 129.8, 135.8, 136.0 (C-Ar,
N–CH=CH), 173.8 (C=O), 179.6 (C=N), 182.9 (C=S). Anal.Calcd for
C33H28N4O3S2 (592.73): C, 66.87; H, 4.76; N, 9.45; S, 10.82%. Found:
C, 66.90; H, 4.71; N, 9.53; S, 10.70%.
1
1658 (C=S), 1554 (C=N) cm−1. H NMR (400 MHz, DMSO-d6):
δ = 1.02–1.46 (10 H, m, 5CH2), 2.37 (3 H, s, CH3), 2.38 (3 H, s, CH3),
2.73–2.75 (1 H, m, CH), 4.34 (1 H, s, CH), 6.08–7.65 (14 H, m, H-Ar,
N–CH=CH), 7.90 (1 H, s, CH), 9.4 (1 H, s, NH). 13C NMR (100 MHz,
DMSO-d6): δ = 29.2 (CH2), 29.9 (CH2), 30.5 (CH2), 30.9 (CH2), 31.2
(CH2), 55.3 (CH), 72.9 (C), 90.0 (N–CH–N), 115.1, 122.4, 124.5,
125.7, 126.2, 127.3, 128.2, 129.0, 130.1, 131.3, 136.8, 143.9 (C-Ar,
N–CH=CH), 176.5 (C=O), 182.7 (C=N), 182.9 (C=S). MS (EI), m/z
534 (M, 2%), 222 (3), 520 (6), 194 (2), 91 (15), 83 (9), 43 (100). Anal.
Calcd for C33H34N4OS (534.71): C, 74.12; H, 6.41; N, 10.48; S, 6.00%.
Found: C, 74.20; H, 6.32; N, 10.56; S, 6.12%.
5,5-bis(4-Chlorophenyl)-2-thioxo-3-{2-[(tosylmethylimino)methyl]-
1,2-dihydroisoquinolin-1-yl}imidazolidin-4-one (4g): White crystals;
m.p. 226–228 °C. yield (0.59 g, 90%). IR (KBr): 1699 (C=O), 1648
1
(C=S), 1560 (C=N) cm−1. H NMR (400 MHz, DMSO-d6): δ = 2.33
(3 H, s, CH3), 4.66–4.67 (2 H, d, CH2), 4.37 (1 H, s, CH), 6.11–7.51
(18 H, m, H-Ar, N–CH=CH), 8.10 (1 H, s, CH), 9.59 (1 H, s, NH).
13C NMR (100 MHz, DMSO-d6): δ = 23.8 (CH3), 80.2 (C), 89.1 (CH2),
93.5 (N–CH–N), 113.8, 123.2, 125.4, 125.9, 126.0, 126.9, 127.8,
128.2, 129.1, 129.7, 129.9, 130.8, 136.5, 139.7 (C-Ar, N–CH=CH),
173.2(C=O),180.1(C=N),183.2(C=S).Anal.CalcdforC33H26Cl2N4O3S2
(661.62): C, 59.91; H, 3.96; N, 8.47; S, 9.69%. Found: C, 59.82; H,
3.85; N, 8.58; S, 9.52%.
3-{2-[(t-Butylimino)methyl]-1,2-dihydroisoquinolin-1-yl}-5,5-diphe-
nyl-2-thioxoimidazolidin-4-one (4h): White crystals; m.p. (decomp.)
209–211 °C. yield (0.40 g, 85%). IR (KBr): 1709 (C=O), 1654 (C=S),
1561 (C=N) cm−1. 1H NMR (400 MHz, DMSO-d6): δ = 1.25 (9 H, s,
3CH3), 4.18 (1 H, s, CH), 6.04–7.54 (16 H, m, H-Ar, N–CH=CH),
8.62 (1 H, s, CH), 9.54 (1 H, s, NH). 13C NMR (100 MHz, DMSO-d6):
5,5-Diphenyl-2-thioxo-3-{2-[(2,4,4-trimethylpentan-2-ylimino)-
methyl]-1,2-dihydroisoquinolin-1-yl}imidazolidin-4-one (4d): White
crystals; m.p. 217–220 °C. yield (0.49 g, 92%). IR (KBr): 1702 (C=O),
1
1657 (C=S), 1550 (C=N) cm−1. H NMR (400 MHz, DMSO-d6):
δ = 1.25 (9 H,s, 3CH3), 1.27 (3 H, s, CH3), 1.31 (3 H, s, CH3), 1.64
(2 H, d, CH2), 4.23 (1 H, s, CH), 6.14–7.52 (16 H, m, H-Ar, N–
CH=CH), 8.04 (1 H, s, CH), 9.54 (1 H, s, NH). 13C NMR (100 MHz,
DMSO-d6): δ = 29.1 (C(CH3)2), 29.9 (C(CH3)2), 31.6 (C(CH3)3), 32.0
(CH2), 55.2 (C(CH3)3), 58.1 (C(CH3)2), 80.4 (C), 90.3 (N–CH–N),
116.8, 124.3, 125.9, 126.7, 126.9, 127.8, 128.4, 129.1, 130.5, 132.4,
135.1, 139.3 (C-Ar, N–CH=CH), 168.8 (C=O), 178.7 (C=N), 182.7
(C=S). Anal.Calcd for C33H36N4OS (536.73): C, 73.85; H, 6.76; N,
10.44; S, 5.97%. Found: C, 73.74; H, 6.86; N, 10.50; S, 5.89%.